{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:40:08Z","timestamp":1793947208924,"version":"4.8.0"},"reference-count":286,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.clinthera.2014.09.020","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T02:53:23Z","timestamp":1415156003000},"page":"1489-1511.e4","source":"Crossref","is-referenced-by-count":113,"title":["Neurotoxicity with Antimicrobials in the Elderly: A Review"],"prefix":"10.1016","volume":"36","author":[{"given":"Arun","family":"Mattappalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.","family":"Mergenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.09.020_bib1","series-title":"A Profile of Older Americans: 2013","year":"2013"},{"key":"10.1016\/j.clinthera.2014.09.020_bib2","series-title":"Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009","year":"2011"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib3","first-page":"1","article-title":"Deaths: preliminary data for 2011","volume":"61","author":"Hoyert","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70309-6","article-title":"Antibiotic side effects","volume":"85","author":"Cunha","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2014.09.020_bib7","series-title":"The Merck Manual","article-title":"Changes in the Body with Aging","author":"Besdine","year":"2013"},{"key":"10.1016\/j.clinthera.2014.09.020_bib8","series-title":"Encyclopaedia of Occupational Health and Safety","article-title":"Chemical Neurotoxic Agents","author":"Arlien-S\u00f8borg","year":"2011"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/11587280-000000000-00000","article-title":"Quinolones: review of psychiatric and neurological adverse reactions","volume":"34","author":"Tom\u00e9","year":"2011","journal-title":"Drug Saf"},{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2014.09.020_bib10","first-page":"S1397","article-title":"Comparison of the inhibitory effects of new quinolines on gamma-aminobutyric-acid receptor binding in the presence of anti-inflammatory drugs","volume":"1989","author":"Hori","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.42.7.1831","article-title":"Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model","volume":"42","author":"Schmuck","year":"1998","journal-title":"Antimicrobial Agents Chemother (Bethesda)"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib12","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/AAC.37.7.1497","article-title":"Quinolones potentiate cefazolin-induced seizures in DBA\/2 mice","volume":"37","author":"De Sarro","year":"1993","journal-title":"Antimicrobial Agents Chemother (Bethesda)"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1592\/phco.21.1.35.34440","article-title":"Gatifloxacin, an advanced 8-methoxy fluoroquinolone","volume":"21","author":"Fish","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2014.09.020_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2165\/00003495-199500492-00005","article-title":"Classification and structure-activity relationships of fluoroquinolones","volume":"49","author":"Bryskier","year":"1995","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","article-title":"Safety considerations of fluoroquinolones in the elderly: an update","volume":"27","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2014.09.020_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000057839","article-title":"Comparison of side effects of levofloxacin versus other fluoroquinolones","volume":"47","author":"Carbon","year":"2001","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.revmed.2006.02.003","article-title":"Centres R\u00e9gionaux de Pharmacovigilance. Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database [in French]","volume":"27","author":"Doussau de Bazignan","year":"2006","journal-title":"Rev Med Interne"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","article-title":"Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability","volume":"275","author":"Inouye","year":"1996","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.clinthera.2014.09.020_bib19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/archinte.167.13.1406","article-title":"Risk factors for delirium at discharge: development and validation of a predictive model","volume":"167","author":"Inouye","year":"2007","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/667743","article-title":"Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria","volume":"33","author":"Stone","year":"2012","journal-title":"Infect Control Hospital Epidemiol"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib21","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/clinids\/20.6.1563","article-title":"Clarithromycin-induced mania in two patients with AIDS","volume":"20","author":"Nightingale","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocn.2010.08.014","article-title":"Clarithromycin-induced neurotoxicity in adults","volume":"18","author":"Bandettini di Poggio","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin","volume":"50","author":"Westphal","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004850-199707000-00007","article-title":"Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients","volume":"12","author":"Yasui","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib25","first-page":"1096","article-title":"[Carbamazepine and clarithromycin: a clinically relevant drug interaction]","volume":"163","author":"Gelisse","year":"2007","journal-title":"Rev Neurol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/106002809502900506","article-title":"Delirium probably induced by clarithromycin in a patient receiving fluoxetine","volume":"29","author":"Pollak","year":"1995","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib27","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.05.022","article-title":"The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin","volume":"119","author":"Jaber","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0090-3019(03)00065-X","article-title":"Delirium in the elderly resulting from azithromycin therapy","volume":"59","author":"Cone","year":"2003","journal-title":"Surg Neurol"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/sti.77.4.297","article-title":"Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART)","volume":"77","author":"Prime","year":"2001","journal-title":"Sex Transm Infect"},{"issue":"8764","key":"10.1016\/j.clinthera.2014.09.020_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(91)91046-W","article-title":"Adverse reactions to co-trimoxazole in HIV infection","volume":"338","author":"van der Ven","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome","volume":"100","author":"Gordin","year":"1984","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jama.1942.02830230001001","article-title":"Nervous and mental effects of the sulfonamides","volume":"119","author":"Little","year":"1942","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib33","first-page":"269","article-title":"Acute psychosis in a patient receiving trimethoprim-sulfamethoxazole intravenously","volume":"47","author":"Mermel","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/070674379303800114","article-title":"Acute psychosis associated with oral trimethoprim-sulfamethoxazole therapy","volume":"38","author":"Gregor","year":"1993","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2006-950393","article-title":"Cotrimoxazole-induced psychosis: a case report and review of literature","volume":"39","author":"Weis","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib36","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1542\/peds.2004-1352","article-title":"Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration","volume":"115","author":"Saidinejad","year":"2005","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)80097-6","article-title":"Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole","volume":"90","author":"McCue","year":"1991","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/jac\/dkr050","article-title":"\u2018Septrin psychosis\u2019 among renal transplant patients with Pneumocystis jirovecii pneumonia","volume":"66","author":"Walker","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib39","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/jac\/dks283","article-title":"Acute psychosis related to use of trimethoprim\/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/bchm3.1989.370.1.101","article-title":"Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients","volume":"370","author":"Eck","year":"1989","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"8675","key":"10.1016\/j.clinthera.2014.09.020_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","article-title":"Systemic glutathione deficiency in symptom-free HIV-seropositive individuals","volume":"2","author":"Buhl","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-3565(25)24502-5","article-title":"Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides","volume":"244","author":"Rieder","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3945\/ajcn.110.003483","article-title":"Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation","volume":"94","author":"Sekhar","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"6135","key":"10.1016\/j.clinthera.2014.09.020_bib44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.1232972","article-title":"Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs","volume":"340","author":"Haruki","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2013.10.016","article-title":"Trimethoprim-sulfamethoxazole-related hallucinations","volume":"36","author":"Stuhec","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1345\/aph.1L295","article-title":"Probable trimethoprim\/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man","volume":"43","author":"Dakin","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2014.09.020_bib47","unstructured":"McEvoy G. AHFS: Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2014."},{"key":"10.1016\/j.clinthera.2014.09.020_bib48","unstructured":"Centers for Disease Control and Prevention. HIV Among Older Americans. 2014. http:\/\/www.cdc.gov\/hiv\/risk\/age\/olderamericans\/index.html. Accessed September 14 2014."},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/QAD.0b013e3280f774ee","article-title":"Chronic renal failure among HIV-1-infected patients","volume":"21","author":"Mocroft","year":"2007","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib50","first-page":"778","article-title":"Report of a Working Group of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-005-0021-y","article-title":"Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside","volume":"24","author":"Chow","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.020_bib52","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/schbul\/sbt052","article-title":"Reduced binding potential of GABA-A\/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study","volume":"40","author":"Kang","year":"2014","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP58327","article-title":"Piperacillin\/Tazobactam inducing seizures in a hemodialysed patient","volume":"58","author":"Bassilios","year":"2002","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib55","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/ndt\/gfh048","article-title":"Piperacillin\/tazobactam-induced acute delirium in a peritoneal dialysis patient","volume":"19","author":"Tong","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MAJ.0b013e31803195e7","article-title":"Piperacillin\/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis","volume":"333","author":"Lin","year":"2007","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s15010-009-8373-3","article-title":"Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure","volume":"37","author":"Huang","year":"2009","journal-title":"Infection"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.020_bib58","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00134-006-0421-1","article-title":"Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients","volume":"32","author":"Conil","year":"2006","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1345\/aph.17228","article-title":"Ampicillin-induced neurotoxicity in very-low-birth-weight neonates","volume":"32","author":"Shaffer","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/ajp.143.2.255b","article-title":"Amoxacillin-induced psychosis?","volume":"143","author":"Beal","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.020_bib61","doi-asserted-by":"crossref","first-page":"a2117","DOI":"10.1136\/bmj.a2117","article-title":"Acute psychosis caused by co-amoxiclav","volume":"337","author":"Bell","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00006454-198709000-00024","article-title":"Behavioral changes after amoxicillin-clavulanate","volume":"6","author":"Macknin","year":"1987","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1176\/jnp.11.4.517-a","article-title":"Penicillin psychosis in later life: Hoigne\u2019s syndrome revisited","volume":"11","author":"Rao","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1742-1241.1996.tb09549.x","article-title":"Amoxycillin-induced hallucinations--a variant of Hoigne\u2019s syndrome?","volume":"50","author":"Stell","year":"1996","journal-title":"Br J Clin Pract"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","article-title":"Efficacy and safety of cefepime: a systematic review and meta-analysis","volume":"7","author":"Yahav","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","article-title":"Cefepime-induced encephalopathy","volume":"8","author":"Dakdouki","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib67","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","article-title":"Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review","volume":"26","author":"Lam","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00134-001-1170-9","article-title":"Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure","volume":"28","author":"Chatellier","year":"2002","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib69","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1212\/01.wnl.0000187079.12413.6a","article-title":"Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function","volume":"65","author":"Capparelli","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yebeh.2005.09.010","article-title":"Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function","volume":"8","author":"Maganti","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.emc.2010.08.006","article-title":"Nonconvulsive status epilepticus","volume":"29","author":"Chang","year":"2011","journal-title":"Emerg Medicine Clin N Am"},{"key":"10.1016\/j.clinthera.2014.09.020_bib72","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm309661.htm. 2012. Accessed 7\/6\/2014 2014."},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1310\/hpj4407-557","article-title":"Cefepime-Induced Neurotoxicity: A Review of the Evidence","volume":"44","author":"Zemrak","year":"2009","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.clinthera.2014.09.020_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/hdi.12198","article-title":"Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature","author":"Mani","year":"2014","journal-title":"Hemodial Int"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib75","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","article-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","volume":"23","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0303-8467(88)90013-3","article-title":"Myoclonic activity associated with cefmetazole, with a review of neurotoxicity of cephalosporins","volume":"90","author":"Uchihara","year":"1988","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib77","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1248\/bpb.24.1049","article-title":"Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats","volume":"24","author":"Nagata","year":"2001","journal-title":"Biol Pharm Bull"},{"issue":"8383","key":"10.1016\/j.clinthera.2014.09.020_bib78","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(84)92425-5","article-title":"Psychotic reaction to cefuroxime","volume":"1","author":"Vincken","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib80","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jac\/dkl354","article-title":"Two decades of imipenem therapy","volume":"58","author":"Rodloff","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-4274(95)80008-2","article-title":"Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem\/cilastatin and meropenem","volume":"76","author":"Day","year":"1995","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0300-483X(99)00078-5","article-title":"Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners","volume":"138","author":"Jin","year":"1999","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib83","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"issue":"1-2","key":"10.1016\/j.clinthera.2014.09.020_bib84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tox.2006.02.004","article-title":"Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics","volume":"222","author":"Horiuchi","year":"2006","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib85","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7164\/antibiotics.48.408","article-title":"Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain","volume":"48","author":"Sunagawa","year":"1995","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.clinthera.2014.09.020_bib87","unstructured":"Merck. Primaxin (imipenem-cilastatin) package insert. Merck: Whitehouse Station, NJ; 2010."},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00365549950161808","article-title":"Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem","volume":"31","author":"Norrby","year":"1999","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib89","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/imj.12504","article-title":"Ertapenem-associated psychosis and encephalopathy","volume":"44","author":"Oo","year":"2014","journal-title":"Int J Med"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11096-013-9812-x","article-title":"Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism","volume":"35","author":"Shea","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib91","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5414\/CN107247","article-title":"Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure","volume":"80","author":"Wen","year":"2013","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib92","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1345\/aph.1P528","article-title":"Central nervous system toxicity associated with ertapenem use","volume":"45","author":"Duquaine","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2014.09.020_bib93","article-title":"Meropenem delirium: a previously unrecognized neurologic side effect","author":"Munoz-Gomez","year":"2014","journal-title":"J Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib94","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib95","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(04)01109-0","article-title":"Peripheral neuropathy associated with prolonged use of linezolid","volume":"4","author":"Bressler","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib96","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/01.wnl.0000201313.24970.b8","article-title":"Linezolid-associated toxic optic neuropathy","volume":"66","author":"Rucker","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s15010-005-4057-9","article-title":"Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases","volume":"33","author":"Ferry","year":"2005","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib98","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1086\/381762","article-title":"Linezolid-induced neuropathy","volume":"38","author":"Legout","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4065\/79.7.927","article-title":"Linezolid-associated peripheral neuropathy","volume":"79","author":"Rho","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib100","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/jac\/dkh405","article-title":"Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6","volume":"54","author":"Spellberg","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib101","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1212\/01.WNL.0000152883.53691.5B","article-title":"Severe sensory neuropathy associated with long-term linezolid use","volume":"64","author":"Zivkovic","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib102","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneur.64.5.746","article-title":"Linezolid-induced posterior reversible leukoencephalopathy syndrome","volume":"64","author":"Nagel","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib103","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/pds.1320","article-title":"Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy","volume":"16","author":"Azamfirei","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1345\/aph.1D018","article-title":"Acute delirium associated with combined diphenhydramine and linezolid use","volume":"38","author":"Serio","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00415-009-5340-y","article-title":"Early onset probable linezolid-induced encephalopathy","volume":"257","author":"Fletcher","year":"2010","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib106","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.020_bib107","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/430441","article-title":"Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?","volume":"40","author":"Palenzuela","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00365540410026022","article-title":"Linezolid use associated with lactic acidosis","volume":"37","author":"Kopterides","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib109","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2007.04.005","article-title":"The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria","volume":"26","author":"Leach","year":"2007","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib110","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","article-title":"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones","volume":"50","author":"McKee","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-3565(25)11738-2","article-title":"Effects of scopolamine and atropine electroencephalographic and behavioral reactions due to hypothalamic stimulation","volume":"116","author":"Longo","year":"1956","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib113","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOO.0b013e3282ef772d","article-title":"Aminoglycoside ototoxicity","volume":"15","author":"Rizzi","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0196-0709(86)80040-0","article-title":"Aminoglycoside ototoxicity","volume":"7","author":"Matz","year":"1986","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2014.09.020_bib116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jama.1963.03710010052007","article-title":"Auditory Ototoxicity in Tuberculosis Patients Treated with a Report of the Incidence of Hearing Loss in a Series of 1,150 Cases","volume":"186","author":"Heck","year":"1963","journal-title":"JAMA"},{"issue":"10 Pt 2 Suppl 24","key":"10.1016\/j.clinthera.2014.09.020_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1288\/00005537-198010001-00001","article-title":"Aminoglycoside ototoxicity in the human","volume":"90","author":"Fee","year":"1980","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib118","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2014.09.020_bib119","doi-asserted-by":"crossref","first-page":"937861","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.410040618","article-title":"Neurotoxicity of intrathecal gentamicin: a case report and experimental study","volume":"4","author":"Watanabe","year":"1978","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib121","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00000542-197809000-00018","article-title":"A possible hazard of prolonged neuromuscular blockade by amikacin","volume":"49","author":"Hashimoto","year":"1978","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib122","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2044.1978.tb08398.x","article-title":"Tobramycin and neuromuscular blockade","volume":"33","author":"Boliston","year":"1978","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib123","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000542-197903000-00010","article-title":"Interaction of neuromuscular blocking effects of neomycin and polymyxin B","volume":"50","author":"Lee","year":"1979","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib124","first-page":"45","article-title":"Neuromuscular blocking activity of aminoglycoside antibiotics","volume":"2","author":"Paradelis","year":"1980","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib125","first-page":"3","article-title":"Gentamicin neurotoxicity (polyneuropathy\u2212encephalopathy) [in German]","volume":"107","author":"Bischoff","year":"1977","journal-title":"Schweiz Med Wochenschr"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib126","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.1982.03320340073043","article-title":"Possible tobramycin delirium","volume":"247","author":"McCartney","year":"1982","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib127","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00007611-197510000-00025","article-title":"Acute toxic psychosis associated with gentamicin therapy","volume":"68","author":"Kane","year":"1975","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-103-1-161_1","article-title":"Neurotoxicity of metronidazole","volume":"103","author":"Alston","year":"1985","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/106002808201600511","article-title":"Convulsions associated with high cumulative doses of metronidazole","volume":"16","author":"Halloran","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.clinthera.2014.09.020_bib131","first-page":"1104","article-title":"Metronidazole","volume":"22","author":"Groman","year":"2000","journal-title":"Compend Cont Educ"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib132","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/08830738060210051201","article-title":"Metronidazole: newly recognized cause of autonomic neuropathy","volume":"21","author":"Hobson-Webb","year":"2006","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib133","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1442-9071.2007.01537.x","article-title":"Reversible optic neuropathy due to metronidazole","volume":"35","author":"McGrath","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"issue":"3 Pt 1","key":"10.1016\/j.clinthera.2014.09.020_bib134","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.45.3.588","article-title":"Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy","volume":"45","author":"Ahmed","year":"1995","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5326\/15473317-37-3-258","article-title":"Metronidazole neurotoxicosis in two cats","volume":"37","author":"Cavlor","year":"2001","journal-title":"Am Anim Hosp Assoc"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib136","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1939-1676.2003.tb02452.x","article-title":"Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases","volume":"17","author":"Evans","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.clinthera.2014.09.020_bib137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1752-1947-5-63","article-title":"Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report","volume":"5","author":"Kim","year":"2011","journal-title":"J Med Case Rep"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib138","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1017\/S0317167100012531","article-title":"Serially changing metronidazole-induced encephalopathy","volume":"38","author":"Kim","year":"2011","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib139","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3174\/ajnr.A0655","article-title":"MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings","volume":"28","author":"Kim","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.12968\/hmed.2009.70.4.41632","article-title":"Organic psychosis induced by ofloxacin and metronidazole","volume":"70","author":"Koul","year":"2009","journal-title":"Br J Hosp Med (Lond)"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib141","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/ajp.154.8.1170b","article-title":"Metronidazole-induced psychotic disorder","volume":"154","author":"Schreiber","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00004836-200304000-00024","article-title":"Metronidazole and mental confusion","volume":"36","author":"Mahl","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"18","key":"10.1016\/j.clinthera.2014.09.020_bib143","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJM196905012801807","article-title":"Toxicity of disulfiram combined with metronidazole","volume":"280","author":"Rothstein","year":"1969","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib144","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.jcp.0000426185.68487.9a","article-title":"Psychotic symptoms after combined metronidazole-disulfiram use","volume":"33","author":"Luykx","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib145","first-page":"33","article-title":"Psychosis induced by cefuroxime and metronidazole","volume":"69","author":"Zahiruddin","year":"2014","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.clinthera.2014.09.020_bib146","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(64)90109-1","article-title":"The Inhibition of Dopamine-Beta-Hydroxylase by Tropolone and Other Chelating Agents","volume":"13","author":"Goldstein","year":"1964","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib147","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-3565(25)27684-4","article-title":"The effect of disulfiram on catecholamine levels in the brain","volume":"157","author":"Goldstein","year":"1967","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib148","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00003088-198308010-00003","article-title":"Clinical pharmacokinetics of metronidazole","volume":"8","author":"Ralph","year":"1983","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2014.09.020_bib149","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1007\/PL00022395","article-title":"Inhibition of monoamine oxidase by metronidazole","volume":"50","author":"Befani","year":"2001","journal-title":"Inflamm Res"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/j.1875-9114.1982.tb03216.x","article-title":"Mental confusion in a patient treated with metronidazole--a concentration-related effect?","volume":"2","author":"Schentag","year":"1982","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib151","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/AAC.6.6.691","article-title":"Pharmacokinetics of metronidazole as determined by bioassay","volume":"6","author":"Ralph","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"issue":"6087","key":"10.1016\/j.clinthera.2014.09.020_bib152","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.2.6087.610","article-title":"Metronidazole neuropathy","volume":"2","author":"Bradley","year":"1977","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.020_bib153","first-page":"918","article-title":"Metronidazole-peripheral neuropathy","volume":"30","author":"Pais","year":"1982","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib154","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib155","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2014.09.020_bib156","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-57-2-214","article-title":"The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients","volume":"57","author":"Fekety","year":"1962","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2014.09.020_bib157","first-page":"163","article-title":"Myasthenic syndrome associated with antibiotics","volume":"92","author":"McQuillen","year":"1967","journal-title":"Trans Am Neurol Assoc"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib158","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cpt1970113418","article-title":"Effect of tetracycline, polymyxin B, and rifampin on phagocytosis","volume":"11","author":"Hoeprich","year":"1970","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2014.09.020_bib159","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.1964.03070180019004","article-title":"Apnea with Intramuscular Colistin Therapy","volume":"190","author":"Perkins","year":"1964","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0952-8180(93)90017-9","article-title":"Interaction of antibiotics on pipecuronium-induced neuromuscular blockade","volume":"5","author":"de Gouw","year":"1993","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib161","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archneur.1971.00490020059006","article-title":"Respiratory arrest in myasthenia gravis with colistimethate therapy","volume":"25","author":"Decker","year":"1971","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib162","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/jac\/dkq185","article-title":"Removal of colistin during intermittent haemodialysis in two critically ill patients","volume":"65","author":"Marchand","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib163","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","article-title":"Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration","volume":"49","author":"Li","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib164","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00000542-197607000-00015","article-title":"Clindamycin enhances a nondepolarizing neuromuscular blockade","volume":"45","author":"Becker","year":"1976","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib165","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-2044.1987.tb04111.x","article-title":"Prolongation of neuromuscular blocking effect of vecuronium by antibiotics","volume":"42","author":"Jedeikin","year":"1987","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib166","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00000542-197410000-00023","article-title":"Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin","volume":"41","author":"Fogdall","year":"1974","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib167","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF03011880","article-title":"Clindamycin-induced neuromuscular blockade","volume":"42","author":"al Ahdal","year":"1995","journal-title":"Can J Anaesth"},{"issue":"5733","key":"10.1016\/j.clinthera.2014.09.020_bib168","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/281680a0","article-title":"Clindamycin and lincomycin alter miniature endplate current decay","volume":"281","author":"Fiekers","year":"1979","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib169","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1213\/00000539-197705000-00001","article-title":"Comparative neuromuscular effects of lincomycin and clindamycin","volume":"56","author":"Rubbo","year":"1977","journal-title":"Anesthesia Analgesia"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.020_bib170","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/bja\/54.12.1295","article-title":"Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics","volume":"54","author":"Singh","year":"1982","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib171","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0278-2391(99)90083-6","article-title":"Neuromuscular blockade after clindamycin administration: a case report","volume":"57","author":"Best","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.clinthera.2014.09.020_bib172","first-page":"753","article-title":"Polyneuropathy due to nitrofurantoin therapy. [in Danish]","volume":"118","author":"De Olivarius","year":"1956","journal-title":"Ugeskr Laeger"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib173","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.23.5.554","article-title":"Nitrofurantoin polyneuropathy","volume":"23","author":"Toole","year":"1973","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib174","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1445-5994.1971.tb02297.x","article-title":"Furadantin neuropathy","volume":"1","author":"Craven","year":"1971","journal-title":"Aust N Z J Med"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1445-5994.1981.tb03521.x","article-title":"Nitrofurantoin neuropathy","volume":"11","author":"Yiannikas","year":"1981","journal-title":"Aust N Z J Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib176","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.WNL.0000070781.92512.A4","article-title":"Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies","volume":"61","author":"Lauria","year":"2003","journal-title":"Neurology"},{"issue":"2 Pt 2","key":"10.1016\/j.clinthera.2014.09.020_bib177","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/01.AOG.0000267134.21517.41","article-title":"Nitrofurantoin neuropathy: a forgotten adverse effect","volume":"110","author":"Kammire","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib178","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.20713","article-title":"Uremic neuropathy: clinical features and new pathophysiological insights","volume":"35","author":"Krishnan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib179","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/AAC.11.4.712","article-title":"Side effects of minocycline: a double-blind study","volume":"11","author":"Fanning","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib180","first-page":"153","article-title":"Clinical significance of brand versus generic formulations: focus on oral minocycline","volume":"77","author":"Del Rosso","year":"2006","journal-title":"Cutis"},{"issue":"558","key":"10.1016\/j.clinthera.2014.09.020_bib181","first-page":"105","article-title":"A new tetracycline minocycline compared with ampicillin in general practice","volume":"83","author":"Gallagher","year":"1976","journal-title":"N Z Med J"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib182","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/AAC.12.5.642","article-title":"Side effects of minocycline: different dosage regimens","volume":"12","author":"Gump","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib183","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5694\/j.1326-5377.1989.tb136591.x","article-title":"A prospective single-blind trial of minocycline and doxycycline in the treatment of genital Chlamydia trachomatis infection in women","volume":"150","author":"Kovacs","year":"1989","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib184","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1902\/jop.1992.63.1.13","article-title":"Gingival crevicular fluid concentration and side effects of minocycline: a comparison of two dose regimens","volume":"63","author":"Freeman","year":"1992","journal-title":"J Periodontol"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","article-title":"Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs","volume":"8","author":"Barza","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib186","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.8.4.453","article-title":"Vestibular reactions associated with minocycline","volume":"8","author":"Jacobson","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib187","first-page":"44","article-title":"Weight-based Dosing and Extended-release Formulation of Minocycline Tablets: Is There Clinical Significance?","volume":"2","year":"2009","journal-title":"J Clin Aesth Dermatol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib188","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jmg.19.5.354","article-title":"The effect of minocycline on potassium leakage from red cells: a study of the genetics and relationship to vestibular adverse reactions","volume":"19","author":"Lannigan","year":"1982","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib189","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9394(98)00063-4","article-title":"Minocycline treatment and pseudotumor cerebri syndrome","volume":"126","author":"Chiu","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0753-3322(92)90026-4","article-title":"Minocycline and benign intracranial hypertension","volume":"46","author":"Donnet","year":"1992","journal-title":"Biomed Pharmacother"},{"issue":"6257","key":"10.1016\/j.clinthera.2014.09.020_bib191","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.282.6257.19","article-title":"Tetracycline and benign intracranial hypertension: report of five cases","volume":"282","author":"Walters","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib192","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0404.2004.00327.x","article-title":"The outcome of pseudotumor cerebri induced by tetracycline therapy","volume":"110","author":"Kesler","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clinthera.2014.09.020_bib193","doi-asserted-by":"crossref","first-page":"203583","DOI":"10.1155\/2009\/203583","article-title":"Minocycline-associated pseudotumor cerebri with severe papilledema","volume":"2009","author":"Bababeygy","year":"2009","journal-title":"J Ophthalmol"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib194","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/SMJ.0b013e31818f98f0","article-title":"Doxycycline-induced pseudotumor cerebri","volume":"102","author":"Tabibian","year":"2009","journal-title":"South Med J"},{"key":"10.1016\/j.clinthera.2014.09.020_bib195","first-page":"161","article-title":"Minocycline-induced benign intracranial hypertension","volume":"26","author":"Lander","year":"1989","journal-title":"Clin Exp Neurol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib196","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1212\/WNL.45.1.6","article-title":"Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review","volume":"45","author":"Gardner","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib197","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-3476(78)80326-6","article-title":"Tetracycline-associated intracranial hypertension in an adolescent: a complication of systemic acne therapy","volume":"92","author":"Stuart","year":"1978","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib198","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0895-4356(01)00349-3","article-title":"Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly","volume":"54","author":"Tromp","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2014.09.020_bib199","series-title":"Itraconazole [package insert]","year":"2012"},{"key":"10.1016\/j.clinthera.2014.09.020_bib200","series-title":"Voriconazole [package insert]","year":"2011"},{"key":"10.1016\/j.clinthera.2014.09.020_bib201","series-title":"Fluconazole [package insert]","year":"2004"},{"key":"10.1016\/j.clinthera.2014.09.020_bib202","series-title":"Posaconazole [package insert]","year":"2014"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib203","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1176\/appi.psy.44.3.260","article-title":"Itraconazole-induced delirium","volume":"44","author":"Mittal","year":"2003","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archneur.62.1.144","article-title":"Painful peripheral neuropathy associated with voriconazole use","volume":"62","author":"Tsiodras","year":"2005","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s15010-004-3121-1","article-title":"Voriconazole-induced musical hallucinations","volume":"32","author":"Agrawal","year":"2004","journal-title":"Infection"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib206","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1086\/424662","article-title":"Adverse reactions to voriconazole","volume":"39","author":"Boyd","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"45-46","key":"10.1016\/j.clinthera.2014.09.020_bib207","first-page":"739","article-title":"Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring","volume":"136","author":"Imhof","year":"2006","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib209","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4140\/TCP.n.2008.804","article-title":"Adverse drug events complicate antifungal therapy for pulmonary aspergilloma","volume":"23","author":"Pakyz","year":"2008","journal-title":"Consult Pharm"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib210","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/588844","article-title":"Hallucinations during voriconazole therapy","volume":"47","author":"Zonios","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2014.09.020_bib211","series-title":"NDAs 21-266 and 21-267","article-title":"Background document for the Antiviral Drug Products Advisory Committee Meeting. Voriconazole AC briefing document. October 4, 2001. (voriconazole tablets) (voriconazole injection) Pfizer Global Research & Development","year":"2001"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib212","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1469-0691.2009.02990.x","article-title":"Voriconazole concentrations and outcome of invasive fungal infections","volume":"16","author":"Miyakis","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.09.020_bib213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03319103","article-title":"Geriatric conditions and the risk of adverse drug reactions in older adults: a review","volume":"35","author":"Lattanzio","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2014.09.020_bib214","first-page":"120","article-title":"Safety of ciprofloxacin. A review","volume":"60","author":"Rahm","year":"1989","journal-title":"Scand J Infect Dis Suppl"},{"issue":"8761","key":"10.1016\/j.clinthera.2014.09.020_bib215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0140-6736(91)90403-C","article-title":"Cystic fibrosis and seizures","volume":"338","author":"O\u2019Mahony","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib216","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF01967014","article-title":"Side-effects of quinolones: comparisons between quinolones and other antibiotics","volume":"10","author":"Norrby","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib217","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4321\/S0365-66912007000500009","article-title":"Visual hallucinations secondary to ciprofloxacin treatment [in Spanish]","volume":"82","author":"Asensio-Sanchez","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib218","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/WNL.43.8.1619-a","article-title":"Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state","volume":"43","author":"Isaacson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2014.09.020_bib219","first-page":"116","article-title":"Tolerance of intravenous ciprofloxacin","volume":"60","author":"Thorsteinsson","year":"1989","journal-title":"Scand J Infect Dis Suppl"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib220","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1086\/515104","article-title":"Fluoroquinolone toxicity profiles: a review focusing on newer agents","volume":"28","author":"Lipsky","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"1-2","key":"10.1016\/j.clinthera.2014.09.020_bib221","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(93)90098-8","article-title":"Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate","volume":"624","author":"Manev","year":"1993","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2014.09.020_bib222","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00006454-199312003-00009","article-title":"Overview of the safety profile of clarithromycin suspension in pediatric patients","volume":"12","author":"Craft","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib223","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0272-6386(96)90043-8","article-title":"Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis","volume":"27","author":"Steinman","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib224","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5414\/CPP40020","article-title":"Hallucinations with therapeutic doses of clarithromycin. Int J","volume":"40","author":"Jimenez","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e318185a357","article-title":"Acute psychosis induced by clarithromycin in a healthy adult?","volume":"28","author":"Kouvelou","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib226","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.06.00039006","article-title":"Delirium induced by clarithromycin in a patient with community-acquired pneumonia","volume":"28","author":"Vicente de Vera","year":"2006","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkl480","article-title":"Clarithromycin monotherapy-induced delirium","volume":"59","author":"Ozsoylar","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib228","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(89)80160-3","article-title":"Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature","volume":"87","author":"Joffe","year":"1989","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib229","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinids\/19.3.431","article-title":"Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review","volume":"19","author":"Harrison","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365549009023129","article-title":"Recurrent encephalitis due to trimethoprim intake","volume":"22","author":"Hedlund","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"8298","key":"10.1016\/j.clinthera.2014.09.020_bib231","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(82)90703-6","article-title":"Generalized seizures and ampicillin","volume":"2","author":"Serdaru","year":"1982","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib232","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/000992289703600807","article-title":"Piperacillin-induced seizures","volume":"36","author":"Malanga","year":"1997","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib233","first-page":"89","article-title":"Standard Dose of Piperacillin Induced Neurotoxicity in Advanced Renal Failure","volume":"25","author":"Ye","year":"2011","journal-title":"Acta Nephrol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib234","first-page":"268","article-title":"A case attributed to cefazoline and a review of the literature","volume":"12","author":"Gardner","year":"1978","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/inf.1970.2.issue-1.09","article-title":"Treatment of urinary tract infections with cephalexin","volume":"2","author":"Erikssen","year":"1970","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clinthera.2014.09.020_bib236","first-page":"361","article-title":"Laboratory and clinical experience with cephalexin","volume":"8","author":"Kind","year":"1968","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib237","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5694\/j.1326-5377.1973.tb110518.x","article-title":"Reversible toxic psychosis after cephalexin","volume":"1","author":"Saker","year":"1973","journal-title":"Med J Aust"},{"issue":"4C","key":"10.1016\/j.clinthera.2014.09.020_bib238","first-page":"84","article-title":"Clinical adverse effects during ceftriaxone therapy","volume":"77","author":"Moskovitz","year":"1984","journal-title":"Am J Med"},{"issue":"Suppl A","key":"10.1016\/j.clinthera.2014.09.020_bib239","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/12.suppl_A.399","article-title":"Ceftazidime: aspects of efficacy and tolerance","volume":"12","author":"Foord","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.55.4.333","article-title":"Ceftazidime encephalopathy: absence status and toxic hallucinations","volume":"55","author":"Jackson","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib241","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure","volume":"111","author":"Martinez-Rodriguez","year":"2001","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib242","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jac\/dks012","article-title":"Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports","volume":"67","author":"Durand-Maugard","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib243","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/01.wnl.0000232685.01730.68","article-title":"Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function","volume":"67","author":"Fernandez-Torre","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib244","first-page":"273","article-title":"Effectiveness of early haemodialysis in cefepime-induced neurotoxicity","volume":"33","author":"Heras","year":"2013","journal-title":"Nefrologia"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jac\/dki448","article-title":"Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Paul","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib246","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/j.1552-4604.1988.tb05735.x","article-title":"The efficacy results and safety profile of imipenem\/cilastatin from the clinical research trials","volume":"28","author":"Calandra","year":"1988","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib247","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/165.6.1033","article-title":"beta-Lactam antibiotic-induced release of free endotoxin: in?vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime","volume":"165","author":"Jackson","year":"1992","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib248","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0091-6749(88)91001-9","article-title":"Imipenem cross-reactivity with penicillin in humans","volume":"82","author":"Saxon","year":"1988","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib249","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","article-title":"Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem","volume":"30","author":"Linden","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2014.09.020_bib250","series-title":"Meropenem Package Insert","year":"2005"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib251","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1179\/joc.2004.16.1.62","article-title":"Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam","volume":"16","author":"Teppler","year":"2004","journal-title":"J Chemother"},{"key":"10.1016\/j.clinthera.2014.09.020_bib252","doi-asserted-by":"crossref","unstructured":"Teppler H, Gesser RM, Friedland IR, et?al. Safety and tolerability of ertapenem. J Antimicrob Chemother. 2004;(53 Suppl 2):ii75-ii81.","DOI":"10.1093\/jac\/dkh209"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib253","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5694\/j.1326-5377.2002.tb04797.x","article-title":"Linezolid-induced neuropathy","volume":"177","author":"Corallo","year":"2002","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib254","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM197908233010805","article-title":"Drug therapy: disorders of neuromuscular transmission caused by drugs","volume":"301","author":"Argov","year":"1979","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-101-1-92","article-title":"The neurotoxicity of antibacterial agents","volume":"101","author":"Snavely","year":"1984","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib256","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1977.03280010053022","article-title":"Acute organic brain syndrome associated with gentamicin therapy","volume":"238","author":"Byrd","year":"1977","journal-title":"JAMA"},{"issue":"Suppl A","key":"10.1016\/j.clinthera.2014.09.020_bib257","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/4.suppl_A.31","article-title":"Clinical evaluation of aminoglycoside toxicity: tobramycin versus gentamicin, a preliminary report","volume":"4","author":"Fee","year":"1978","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.020_bib258","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.1971.03180200075022","article-title":"Neuromuscular blockade associated with gentamicin therapy","volume":"215","author":"Warner","year":"1971","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.clinthera.2014.09.020_bib259","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1093\/infdis\/135.Supplement_2.S441","article-title":"A review of results of clinical trials with amikacin","volume":"134","author":"Gooding","year":"1976","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib260","first-page":"1249","article-title":"Experiences with intravenous drip infusion therapy of amikacin for severe infections in patients of hematological disorder [in Japanese]","volume":"35","author":"Hanada","year":"1982","journal-title":"Jpn J Antibiot"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.020_bib261","first-page":"916","article-title":"The neuromuscular blocking property of amikacin (author\u2019s transl) [in Japanese]","volume":"30","author":"Hashimoto","year":"1977","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib262","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1620\/tjem.125.71","article-title":"Neuromuscular blocking property of amikacin in man","volume":"125","author":"Hashimoto","year":"1978","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.020_bib263","first-page":"2813","article-title":"Clinical evaluation of ototoxicity associated with intravenous drip infusion of amikacin [in Japanese]","volume":"36","author":"Maeyama","year":"1983","journal-title":"Jpn J Antibiot"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib264","first-page":"897","article-title":"Clinical studies on amikacin for infectious diseases following intravenous drip infusion (author\u2019s transl) [in Japanese]","volume":"35","author":"Nakamura","year":"1982","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.clinthera.2014.09.020_bib265","first-page":"832","article-title":"Metronidazole Neuropathy","volume":"2","year":"1977","journal-title":"Br Med J"},{"issue":"7910","key":"10.1016\/j.clinthera.2014.09.020_bib266","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(75)92438-1","article-title":"Metronidazole for Crohn\u2019s disease","volume":"1","author":"Ursing","year":"1975","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib267","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9394(14)77290-3","article-title":"Metronidazole and optic neuritis","volume":"112","author":"Putnam","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib268","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0003-9861(87)90577-7","article-title":"Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine","volume":"257","author":"Alston","year":"1987","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib269","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/bbrc.1995.2010","article-title":"Inhibition of diamine oxidase activity by metronidazole","volume":"212","author":"Befani","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.020_bib270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3350\/kjhep.2011.17.2.157","article-title":"Metronidazole-induced encephalopathy in a patient with liver cirrhosis","volume":"17","author":"Cheong","year":"2011","journal-title":"Korean J Hepatol"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.020_bib271","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/clinids\/19.5.974","article-title":"Metronidazole-associated aseptic meningitis","volume":"19","author":"Corson","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib272","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/1061186X.2011.639024","article-title":"Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole","volume":"20","author":"Kim","year":"2012","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.020_bib273","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0028-3886.76882","article-title":"Metronidazole neurotoxicity: sequential neuroaxis involvement","volume":"59","author":"Park","year":"2011","journal-title":"Neurol India"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib274","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJM196908072810623","article-title":"Disulfiram-metronidazole","volume":"281","author":"Rothstein","year":"1969","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib275","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10096-006-0191-2","article-title":"Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria","volume":"25","author":"Falagas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.020_bib276","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkg468","article-title":"Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis","volume":"52","author":"Li","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib277","first-page":"235","article-title":"Effects of polymyxin B on LPS-induced activation of NF-kappaB in pulmonary alveolar macrophages [in Chinese]","volume":"19","author":"Yang","year":"2003","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib278","first-page":"336","article-title":"Apnea due to intramuscular colistin therapy","volume":"62","author":"Anthony","year":"1966","journal-title":"Report of a case. Ohio State Med J"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib279","first-page":"242","article-title":"Sites and mechanisms of antibiotic-induced neuromuscular block: a pharmacological analysis using quantal content, voltage clamped end-plate currents and single channel analysis","volume":"49","author":"Fiekers","year":"1999","journal-title":"Acta Physiol Pharmacol Ther Latinoam"},{"issue":"9192","key":"10.1016\/j.clinthera.2014.09.020_bib280","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0140-6736(99)02881-0","article-title":"Clindamycin and nicotinic neuromuscular transmission","volume":"354","author":"Schulze","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.020_bib281","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.sleep.2007.11.007","article-title":"Clindamycin-induced restless legs syndrome","volume":"9","author":"Lo Coco","year":"2008","journal-title":"Sleep Med"},{"issue":"6327","key":"10.1016\/j.clinthera.2014.09.020_bib282","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.284.6327.1440","article-title":"Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland","volume":"284","author":"Penn","year":"1982","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.020_bib283","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.1967.03120170117034","article-title":"Benign intracranial hypertension in an adult after tetracycline therapy","volume":"200","author":"Koch-Weser","year":"1967","journal-title":"JAMA"},{"issue":"6263","key":"10.1016\/j.clinthera.2014.09.020_bib284","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/bmj.282.6263.568-c","article-title":"Tetracycline and benign intracranial hypertension","volume":"282","author":"Pearson","year":"1981","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.clinthera.2014.09.020_bib285","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.020_bib286","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington\u2019s disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim Biophys Acta"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:31:02Z","timestamp":1747146662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814006122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":286,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0149291814006122"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.09.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}